Antibody

3개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved3 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleImmunoGen, Inc.Phase 2

Lorvotuzumab Mertansine (Lorvotuzumab Mertansine)

Pleuropulmonary Blastoma; Recurrent Malignant Peripheral Nerve Sheath Tumor · Pleuropulmonary Blastoma

#PleuropulmonaryBlastoma#Antibody#Phase2#monoclonal-antibody#RecurrentMalignantPeripheralNerv+1
Trials 7Status Active
AntibodyLimited DatastaleSun Yat-sen UniversityPhase 2

Adebrelimab & SHR2554 (Adebrelimab & SHR2554)

Relapsed or Refractory Peripheral T Cell Lymphoma; NKTCL · FRα

#FR#Antibody#Phase2#monoclonal-antibody#RelapsedorRefractoryPeripheralTC+2
Trials 1Status Recruiting
AntibodyLimited DatastaleNational Cancer Institute (NCI)Phase 1

Siplizumab (Siplizumab)

T-Cell Peripheral Lymphoma; Gamma Delta Hepatosplenic T-Cell Lymphoma · T-Cell Peripheral Lymphoma

#T-CellPeripheralLymphoma#Antibody#Phase1#monoclonal-antibody#GammaDeltaHepatosplenicT-CellLym+1
Trials 1Status Active